NEWS
Scroll Down
2024-12-24CoreTissue BioEngineering announces the renewal of its corporate website2024-11-11Yoji Jokura will present at ”The 62nd Annual Meeting of the Japanese Society for Artificial Organs”2024-10-15CTBE has been selected as a coworking member of the Japan Innovation Campus in Silicon Valley, USA.2024-08-29CTBE announces start of clinical trial for regenerative ligament for ACL reconstruction using decellularization technology2024-07-30Japanese medtech startup, CoreTissue BioEngineering, becomes first company accepted into accelerator program backed by Mitsubishi Corporation (Americas) and Fogarty Innovation2023-11-15Kiyotaka Iwasaki will be on stage as a speaker at the 1st Japanese Knee Society Conference, held on December 8th, 20232023-10-12CTBE will attend JHVS 2023 in Yokohama 2023-07-18We obtained a license for manufacturing and marketing of first-class medical devices.2023-04-07CTBE Selected for AMED “Advanced Medical Devices and Systems Development Project” 2023-02-24Notice of Completion of Series A Funding of Approximately 560 Million Yen2023-02-16Our CEO, Chiaki Waki presented at MedTech Woman’s Career Talk Event on February 6th, 20232023-01-28Our CEO, Chiaki Waki will present at ”Yokohama Japan Health Tech and Wellness Startups Pitch Event” on January 31st 4pm to 6pm PST.2023-01-25Our board chairman, Yoji Jokura, will present at Life Innovation Seminar on January 31st, 20232023-01-11Our CEO, Chiaki Waki presented at BIOTECH SHOWCASE on January 9th, 2023. 2022-11-01Our company has been selected for the "U.S. Life Science Market Development Support Program 2022" sponsored by the Yokohama City2022-10-28Obtained medical device manufacturing license on Oct 18th, 20222022-10-28Our board chairman, Yoji Jokura will present at the 60th Annual Meeting of the Japanese Society of Artificial Organs2022-10-06Our CEO, Chiaki Waki will present at "Medical Device Innovation in Kashiwanoha" on October 28th 4-7pm JST.2022-09-26Our product was introduced on NHK WORLD program "Medical Frontiers"2022-09-10Our CEO, Chiaki Waki will present at ”Shaping the Future of Healthtech” on October 6th 10am-11am JST. 2022-08-08Adopted for San Diego "CONNECT" Acceleration Program2022-06-29Yoji Jokura has been appointed as Board Chairman and Chiaki Waki has been appointed as President&CEO. 2022-03-16CTBE was accepted by Johnson & Johnson Innovation (Boston, U.S.A.) as the first startup company in Japan. It was also interviewed and posted by Nikkei Shimbun.2021-11-11CTBE was introduced by "Venture Tanbou" on "Nikkei Biotechnology & Business".2021-10-20CTBE was elected to "J-Startup", the program for supporting the global startup companies sponsored by Japanese governmental organizations (METI, JETRO and NEDO).2021-10-15CTBE raised fund from SUCCESS program of Japan Science and Technology Agency (JST) . The company will accelerate development of the artificial ligament for ACL reconstruction and business development for the US market.2021-10-11CTBE moved to new office with R/D laboratory and manufacturing facility.2021-07-28CTBE presented at Startup Pitch@CIC sponsored by CIC Tokyo and Tokyo University Biodesign and won a prize.2021-05-18CTBE obtained the manufacturing and marketing authorization of the highly controlled medical devices.2020-12-25AMED adopted CTBE to the Grant, "the 5th CiCLE: Cyclic Innovation for Clinical Empowerment 2020"2020-07-07The annual report of the AMED grant program was published2020-06-22CTBE conducted FDA Pre-Submission with the U.S, Food and Drug Administration (FDA) successfully. For Reference2020-06-18The CEO went onto the online platform of the Joint Pitch - Deep Tech for Good: Medical Innovations sponsored by SGInnovate (Singapore) and Japan Science and Technology Agency (JST)2020-02-12The 2020 renewal of the AMED grant program was approved2019-11-26The CEO went onto the platform of the 34th NEDO Pitch "Academic Venture x Health-tech"2019-11-18Received grant from the Ogasawara Foundation for the Promotion of Science & Engineering2019-10-16Funded as the first investment by Waseda University Official Fund
TOP
